"Premier Eye Institute: Established for over 50 years, we are a comprehensive ophthalmic practice comprised of 8 board-certified Ophthalmologists, and a certified Optometrist"

During the past decade, Fort Lauderdale Eye Institute conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fort Lauderdale Eye Institute" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Jaeb Center for Health Research" with 5 trials sponsored, "Kodiak Sciences Inc" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fort Lauderdale Eye Institute" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Fort Lauderdale Eye Institute" are "Diabetic Macular Edema" (10 trials), "Diabetic Retinopathy" (3 trials), "Macular Edema" (3 trials), "Geographic Atrophy" (2 trials) and "Neovascular Age-Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Fort Lauderdale Eye Institute" in a lesser frequency.

Most popular intervention types in "Fort Lauderdale Eye Institute" are "Drug" (24 trials), "Other" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Faricimab" (7 trials), "Aflibercept" (6 trials), "Deferred aflibercept" (2 trials) and "Deferred laser" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fort Lauderdale Eye Institute" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Fort Lauderdale Eye Institute". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Fort Lauderdale Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fort Lauderdale Eye Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".